Chester County News and Community Website
MALVERN, PA — YPrime has unveiled its latest innovation, the Tender Swollen Joint Count (TSJC) assessment. This tool is designed to revolutionize the way disease activity affecting joints is measured …
YPrime Introduces Innovative Assessment Tool to Enhance Clinical Trials for Autoimmune Diseases Read More
PARSIPPANY, NJ & KING OF PRUSSIA, PA — Ferring Pharmaceuticals has teamed up with SK pharmteco to scale up the commercial manufacturing capacity of ADSTILADRIN (nadofaragene firadenovec-vncg), a gene therapy …
Ferring Pharmaceuticals Partners with SK pharmteco to Boost Gene Therapy Supply Read More
HARRISBURG, PA — Pennsylvania has emerged at the forefront of states advocating for the insurance coverage of over-the-counter (OTC) birth control. Following Governor Josh Shapiro’s appeal to health insurers to …
Pennsylvania Takes Lead in Making Over-the-Counter Birth Control Widely Accessible Read More
PHILADELPHIA, PA — Nimble Therapeutics recently announced the inauguration of its second research and development (R&D) facility in Philadelphia. Situated in B+Labs, a nucleus for scientific innovation within University City …
Nimble Therapeutics Expands with New R&D Site in Philadelphia, Bolsters Leadership Team Read More
EXTON, PA — In a strategic move poised to reshape the pharmaceutical landscape, Japan’s EPNextS Group and US-based Frontage Laboratories, Inc. have announced a partnership aimed squarely at overcoming Japan’s …
EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan’s Drug Development Hurdles Read More
WEST CHESTER, PA — In a significant development for Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), the company announced its lead dermatological product, YCANTH™, has been granted New Chemical Entity (NCE) Status …
Verrica Pharmaceuticals Secures Key FDA Designation for YCANTH, Enhancing Market Protection Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week that the U.S. Food and Drug Administration (FDA) has granted clearance for its NeuroStar Advanced Therapy system as an adjunct …
FDA Clears NeuroStar’s TMS Therapy for Adolescents with Major Depressive Disorder Read More
HONEY BROOK, PA — Provell Pharmaceuticals recently announced a partnership with Mark Cuban’s brainchild Cost Plus Drug Company, PBC (Cost Plus Drugs). They are set on bringing life-saving drugs to …
The Revolution in Drug Pricing: Provell Pharmaceuticals and Cost Plus Drugs Forge New Pathway for Affordable Medication Read More
SPRING HOUSE, PA — Johnson & Johnson announced it recently submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for TREMFYA® (guselkumab). This application …
Johnson & Johnson Seeks FDA Approval for New Ulcerative Colitis Treatment Read More
YARDLEY, PA — The U.S. Food and Drug Administration (FDA) recently approved XHANCE® (fluticasone propionate) nasal spray, developed by Optinose (NASDAQ: OPTN), for the treatment of chronic rhinosinusitis without nasal …
FDA Approves Optinose’s XHANCE as First Treatment for Sinusitis Without Nasal Polyps Read More